Intravenous immunoglobulin (IVIG) therapy involves infusing patients with naturally occurring IgG antibodies to treat autoimmune conditions. With origins dating back to the 1950s, IVIG is currently ...
Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...
QIVIGY is the realization of over 10 years of investments and internal efforts to bring a proprietary IVIG product from concept to commercialization FORT LEE, N.J., Sept. 29, 2025 /PRNewswire/ -- ...
A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care. By Reed Abelson and Teddy Rosenbluth Like millions ...
EARLY treatment with intravenous immunoglobulins (IVIG) significantly improves long-term outcomes and survival in patients with anti-IgLON5 disease, according to findings from a large international ...
Courtesy Getty Images The donor antibodies that a patient is exposed to during IVIG can sometimes react with antigens that are utilized in syphilis screening. Intravenous immunoglobulin (IVIG) is a ...
The following is a summary of “Rituximab combined with intravenous immunoglobulin in autoimmune diseases: a systematic review,” published in the March 2025 issue of Advances in Rheumatology by ...
The following is a summary of “Results of ADVANCE-CIDP IVIG Trial: Intravenous Immunoglobulin 10% Therapy With GAMMAGARD LIQUID/Kiovig for Treatment of Relapse in Chronic Inflammatory Demyelinating ...
Individuals are advised to discontinue use of the affected lots immediately and return the product to the point of purchase for replacement. Several lots of intravenous and subcutaneous immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback